[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts

• Mette Munk Jensen ,

  * E-mail: mettemj@sund.ku.dk

  Affiliations Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Kamille Dumong Erichsen,

  Affiliation TopoTarget A/S, Symbion Science Park, Copenhagen, Denmark

  ⨯
• Camilla Bardram Johnbeck,

  Affiliations Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Fredrik Björkling,

  Current address: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

  Affiliation TopoTarget A/S, Symbion Science Park, Copenhagen, Denmark

  ⨯
• Jacob Madsen,

  Affiliation Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Michael Bzorek,

  Affiliation Department of Pathology, Næstved Hospital, Næstved, Denmark

  ⨯
• Peter Buhl Jensen,

  Affiliation TopoTarget A/S, Symbion Science Park, Copenhagen, Denmark

  ⨯
• Liselotte Højgaard,

  Affiliations Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Maxwell Sehested,

  Affiliation TopoTarget A/S, Symbion Science Park, Copenhagen, Denmark

  ⨯
• Andreas Kjær

  Affiliations Cluster for Molecular Imaging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

  ⨯